Assura | AGR

Stock Price
47.10
Daily Change
0.18 0.38%
Monthly
-4.07%
Yearly
15.22%
Q3 Forecast
46.85

Peers Price Chg Day Year Date
Assura 47.10 0.18 0.38% 15.22% Sep/05
Phoenix Holdings 670.00 9.50 1.44% 19.01% Sep/05
Primary Health Properties 2,111.00 -17.00 -0.80% -9.86% Sep/05
Tate & Lyle 512.00 -2.50 -0.49% -25.04% Sep/05
Waypoint REIT Ltd 2.71 -0.01 -0.37% 1.12% Sep/05
Elme Communities 17.22 0.09 0.53% -1.54% Sep/05


Assura PLC traded at 47.10 this Friday September 5th, increasing 0.18 or 0.38 percent since the previous trading session. Looking back, over the last four weeks, Assura gained 4.07 percent. Over the last 12 months, its price rose by 15.22 percent. Looking ahead, we forecast Assura PLC to be priced at 46.85 by the end of this quarter and at 46.09 in one year, according to Trading Economics global macro models projections and analysts expectations.

Assura plc is a United Kingdom-based diversified healthcare real estate investment trust. The Company is a specialist healthcare property investor and developer. The Company owns and procures primary care properties across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings, so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. It provides customers with spaces to deliver diagnostic, specialist treatment and mental health services. The Company owns and manages a portfolio of about 600 properties. The Company’s subsidiaries include Assura (SC1) Ltd, Assura (SC2) Ltd, Assura Aspire Ltd, Assura Aspire UK Ltd, Assura Development Hub Ltd, Assura Primary Care Properties Ltd, and Assura GHC Ltd, among others.